ST Pharm Co.,Ltd. announced that it expects to receive KRW 100 billion in funding from a group of investors
August 06, 2023
Share
ST Pharm Co.,Ltd. announced a private placement to issue Series 2 unregistered non-guaranteed privately placed convertible bonds for the gross proceeds of KRW 100,000,000,000 on August 7, 2023. The transaction will include participation from new investors, NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., JB Woori Capital Co., Ltd, KIWOOM capital Co.,Ltd., EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., Hanyang Securities Co. Ltd., Kiwoom Securities Co., Ltd., Hi Investment & Securities Co.,Ltd., Lindeman Innovation Growth PEF, a fund managed by, Lindeman Asia Investment Corporation, Korea Investment & Securities Co., Ltd., Shinhan Capital Co., Ltd., LYFE Capital Fund IV (Dragon), L.P., LYFE Capital Fund IV (Dragon), L.P., Hanyang Time Mezzanine New Technology Fund, Cape-the-J-Paros Mezzanine New Technology Fund, Samsung Securities Co., Ltd. The transaction has been approved by the shareholders of the company and is expected to close on August 9, 2023.
LS Securities Co Ltd, formerly EBest Investment & Securities Co Ltd, is a Korea-based company principally engaged in the financial investment and securities services provision business. The Company mainly provides securities investment brokerage services such as equity securities, debt securities, investment securities, investment contract securities, derivatives-linked securities and foreign currency securities, consignment trading services such as real-time ordering, quoting and securities information inquiring for stock futures, options and funds, as well as own trading services. The Company also provides underwriting, arranging and lending services.